Atrial fibrillation and sport: recommendations for athletes

Atrial fibrillation (AF) was once viewed as a disease of older, sedentary Australians, yet growing evidence shows it affects a meaningful number of competitive athletes and recreational sportspeople. Endurance disciplines such as long-distance running, triathlon, open-water swimming, and the high-intensity demands of Australian Rules football and rugby league all place unique stress on cardiac structure and rhythm. For cardiologists, electrophysiologists, and sports physicians working in Sydney, Melbourne, Brisbane, or Perth clinics, balancing the cardiovascular benefits of regular training with the arrhythmia burden seen in some athletes requires careful, individualised counselling.

Local guidance from the Cardiac Society of Australia and New Zealand, alongside position statements published in collections of the Journal of Arrhythmia, has helped frame a practical approach to athletes presenting with palpitations, breathlessness, or documented AF. The following sections summarise how to evaluate symptoms, choose between rate and rhythm control, decide on catheter ablation, and counsel athletes across different sporting codes on safe return to play.

Understanding AF in athletic populations

AF in athletes is most often paroxysmal, triggered by the autonomic shifts that accompany prolonged training, dehydration, and post-exercise recovery. Years of cumulative endurance volume can produce atrial remodelling, with left atrial enlargement observed in elite cyclists, ultramarathon runners, and Ironman competitors who train across the Australian summer months. Recreational athletes participating in mass-participation events such as the Melbourne Marathon or the City2Surf in Sydney also present with new-onset AF, particularly when they ramp up training volume without adequate recovery windows.

The mechanism is multifactorial. Repetitive bouts of high stroke volume during endurance exercise transiently stretch atrial tissue, while inflammation, electrolyte shifts, and elevated catecholamines during intense sessions create a substrate for triggered firing from the pulmonary veins. Australian research groups based at the Baker Heart and Diabetes Institute in Melbourne have contributed substantially to this body of work, and their findings inform many of the contemporary recommendations used in clinic today. AF in this population is not always benign, and athletes should be evaluated for underlying structural heart disease, hypertension, thyroid dysfunction, and sleep apnoea before attributing the arrhythmia solely to training load.

Prevalence estimates vary, but screening studies of Masters-level endurance athletes and community sport participants in Australia consistently report higher rates of AF than in age-matched non-athletic controls. The pattern is most striking in men over 40, although female endurance athletes are not exempt. Identifying affected athletes requires a high index of suspicion, because AF symptoms such as fatigue, reduced exercise tolerance, and palpitations are easily dismissed as expected consequences of heavy training.

Diagnostic pathways and when to refer

Initial assessment begins with a focused history covering training volume, race calendars, hydration practices in hot Australian conditions, and any use of performance supplements or stimulants. A 12-lead ECG, often supplemented by a 24- to 72-hour Holter or a 14-day patch monitor, can characterise arrhythmia burden. For athletes with infrequent symptoms, implantable loop recorders are increasingly considered, particularly when symptoms are disabling or when the diagnosis remains uncertain after non-invasive testing.

Referral to a cardiac electrophysiologist is appropriate when AF is documented, when symptoms interfere with training or competition, or when the athlete is considering long-term pharmacological therapy. Public hospital services in major centres such as Royal Prince Alfred in Sydney, Royal Melbourne, and the Royal Brisbane and Women's Hospital provide tertiary arrhythmia care, while private rooms and dedicated sports cardiology clinics offer rapid access for athletes preparing for upcoming events. Medicare-funded specialist consultations remain the standard referral pathway, and primary care practitioners play a central role in initial triage, anticoagulation decision-making, and ongoing monitoring between specialist reviews.

Wearable technology is reshaping how rhythm data are captured in athletic populations. Smartwatch ECG tracings, chest-strap heart rate devices, and continuous monitoring tools can detect irregularities that prompt further investigation. Coaches and medical staff should be educated to recognise concerning alerts and facilitate rapid assessment when arrhythmia is suspected, particularly during high-stakes competition phases.

Pharmacological considerations for active patients

Rate control with bisoprolol or metoprolol is frequently used in older recreational players, although beta-blockade can blunt heart rate response during high-intensity efforts and reduce training tolerance in elite competitors. For athletes seeking rhythm control, flecainide or sotalol are reasonable choices when there is no underlying coronary disease or significant left ventricular hypertrophy, and pill-in-the-pocket dosing can be practical for those with infrequent paroxysmal episodes triggered by specific events such as a hot-weather race or a high-stakes match.

Anticoagulation decisions deserve particular attention in this group. Many Australian athletes compete in sports with collision risk, including AFL, rugby union and league, and soccer, where direct oral anticoagulants raise concerns about bleeding from head or musculoskeletal trauma. For athletes with contraindications to long-term anticoagulation, left atrial appendage occlusion provides a mechanical alternative that removes the need for ongoing blood-thinning therapy. Specialist input is essential when weighing bleeding risk against stroke risk, and shared decision-making involving the athlete, coach, and team medical staff often yields the most workable outcome.

Athletes often ask whether lifelong medication use is necessary. Concerns about long-term exposure to antiarrhythmic drugs frequently arise, particularly among younger athletes planning decades of competitive participation. Where ablation is feasible, medication burden may be substantially reduced, particularly when modifiable triggers such as alcohol, caffeine, dehydration, and unmanaged sleep apnoea are also addressed.

Catheter ablation and return-to-play timelines

Pulmonary vein isolation has emerged as a first-line option for many athletes with symptomatic paroxysmal or persistent AF, particularly when antiarrhythmic drugs are poorly tolerated or when the athlete wishes to avoid long-term medication use. Success rates in athletic populations are at least comparable to non-athletes, and freedom from atrial arrhythmia can translate into measurable gains in training consistency and competitive performance. Where conduction system disease or ventricular dysfunction coexists, broader resynchronisation strategies such as biventricular pacing challenges may also warrant consideration, although these remain uncommon in the typical athlete population.

Return-to-play decisions after ablation follow a structured progression. Most guidelines suggest two weeks of restricted activity to allow vascular access sites to heal, followed by a graded reintroduction of low-intensity training over the following month. High-intensity efforts and competition are typically resumed from four to six weeks onward, provided there is no evidence of recurrent arrhythmia on ambulatory monitoring. Athletes should be counselled that early recurrences within the first three months are not uncommon and do not necessarily indicate procedural failure, particularly when modifiable triggers such as dehydration, alcohol intake, and sudden intensity spikes are addressed.

Procedure-specific considerations also shape return-to-play timelines. Femoral access site healing, post-ablation inflammation, and short-term anticoagulation requirements influence when full contact and high-intensity training can safely resume. Mature practice frameworks in major centres including Royal Prince Alfred, Royal Melbourne, and leading private electrophysiology laboratories guide athletes through recovery with structured monitoring and shared decision-making protocols.

Sport-specific guidance and risk stratification

Sport classification helps tailor recommendations. Low-static, low-dynamic activities such as golf, lawn bowls, and recreational walking carry minimal additional risk, and athletes with well-controlled AF can usually continue without restriction. Moderate-dynamic disciplines including half-marathons, club-level swimming, and tennis sit in the middle of the spectrum, and most cardiologists permit continued participation once symptoms are controlled and anticoagulation status is settled. High-endurance events and collision sports demand closer scrutiny and individualised planning.

Within Australia, environmental factors add a further layer. Summer training across Brisbane, Perth, and inland New South Wales exposes athletes to heat stress that amplifies AF triggers through dehydration and electrolyte disturbance. AFL and Super Rugby pre-seasons held in February often overlap with peak heat, and team physicians increasingly incorporate hydration monitoring, sleep tracking, and ECG screening into their medical protocols.

Cricket fast bowlers, surf lifesaving competitors, and open-water swimmers all require tailored counselling around pacing, recovery, and warning signs that warrant medical review. For collision-prone codes, return to full contact is typically deferred until anticoagulation strategy is finalised and any post-procedure healing is complete, with competitive match play resumed only when specialist sign-off confirms stable rhythm control. For clinicians seeking a broader evidence base across pacing, ablation, and device therapy, the journal's themed collections offer curated reading lists that complement individual case management.

Clinicians managing athletes with AF are encouraged to draw on the resources available through the Journal of Arrhythmia, including original research, clinical guidelines, and themed collections on electrophysiology and device therapy. Submit your work, explore the latest themed collections, or revisit foundational articles on atrial fibrillation management to stay current with the rapidly evolving evidence base supporting safe sports participation.